This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lipton RB and Silberstein SD (2001) The role of headache-related disability in migraine management: implications for headache treatment guidelines. Neurology 56 (Suppl 1): S35–S42
Lofland JH and Nash DB (2005) Oral serotonin receptor agonists: a review of their cost effectiveness in migraine. Pharmacoeconomics 23: 259–274
Leinisch-Dahlke E et al. (2004) Patient preference in clinical trials for headache medication: the patient's view. Cephalalgia 24: 347–355
Ahrens SP et al. (1999) Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group. Cephalalgia 19: 525–530
Acknowledgements
The synopsis was written by Emma Campbell, Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Evers, S. How effectively do rizatriptan and nontriptan drugs restore functional ability after acute migraine?. Nat Rev Neurol 2, 182–183 (2006). https://doi.org/10.1038/ncpneuro0151
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0151